Fingerprint
Dive into the research topics of 'Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia
Aref Al-Kali, Hagop Kantarjian, Jianqin Shan, Roland Bassett, Alfonso Quintás-Cardama, Gautam Borthakur, Elias Jabbour, Srdan Verstovsek, Susan O'Brien, Jorge Cortes
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations